Show simple item record

dc.contributor.editorLemieux, Isabelle
dc.contributor.editorDesprés, Jean-Pierre
dc.date.accessioned2021-05-01T15:07:22Z
dc.date.available2021-05-01T15:07:22Z
dc.date.issued2021
dc.identifierONIX_20210501_9783039439898_91
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/68346
dc.description.abstractMetabolic syndrome has been the topic of countless publications. It still remains a subject of debate and some experts have even questioned its clinical relevance. Its diagnosis is nevertheless predictive of an increased risk of type 2 diabetes and cardiovascular disease even in the absence of traditional risk factors. Many years ago, our team made the point that the most prevalent form of metabolic syndrome was linked to abdominal obesity, which can be found even among individuals who are not considered obese by body weight standards. Imaging techniques such as computed tomography and magnetic resonance imaging have revealed the link between regional body fat partitioning and cardiometabolic risk. Visceral obesity is the most dangerous form of obesity, with subcutaneous obesity being associated with lower health risk. We have proposed that excess visceral fat may be a marker of subcutaneous adipose tissue dysfunction not being able to serve as a metabolic sink, causing lipid accumulation at undesired sites, a condition described as ectopic fat deposition. Among the effective approaches to prevent, delay, or manage metabolic syndrome, lifestyle changes are the key elements, with an emphasis on the importance of healthy global dietary patterns, regular physical activity, and adequate sleep quality.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::N History and Archaeology::NH Historyen_US
dc.subject.classificationthema EDItEUR::J Society and Social Sciences::JB Society and culture: general::JBF Social and ethical issuesen_US
dc.subject.othertrimethylamine N-oxide (TMAO)
dc.subject.otherobesity
dc.subject.othervisceral adiposity index (VAI)
dc.subject.otherfatty liver index (FLI)
dc.subject.othermetabolic syndrome (MetS)
dc.subject.otherhealthy lifestyle score
dc.subject.othermetabolic syndrome
dc.subject.otherSUN cohort
dc.subject.otherbranched-chain amino acids
dc.subject.otheracylcarnitines
dc.subject.otherdietary protein sources
dc.subject.othermeat
dc.subject.othermetabolite profiling
dc.subject.otherdiet
dc.subject.otherpediatric obesity
dc.subject.othernonalcoholic fatty liver disease
dc.subject.othersaliva
dc.subject.othermetabolomics
dc.subject.othergas-chromatography mass spectrometry
dc.subject.otheranthropometric indexes
dc.subject.otherdiagnosis criteria
dc.subject.otheradolescents
dc.subject.otherbone mineral density
dc.subject.otherinsulin resistance
dc.subject.otherbone health
dc.subject.otherosteoporosis
dc.subject.otheratherosclerotic cardiovascular disease
dc.subject.othervisceral fat accumulation
dc.subject.otheruniversal public health screening program
dc.subject.otherhealth check-up
dc.subject.otherhealth guidance
dc.subject.othercity planning
dc.subject.othercarbohydrate
dc.subject.otherpolyunsaturated fat
dc.subject.othermonounsaturated fat
dc.subject.othersaturated fat
dc.subject.otherfish oil
dc.subject.othermeta-analyses
dc.subject.otherlipids
dc.subject.otherglucose
dc.subject.otherblood pressure
dc.subject.otherbreastfeeding duration
dc.subject.otherbirth weight
dc.subject.othercardiorespiratory fitness
dc.subject.othercardiovascular disease
dc.subject.otherexercise training
dc.subject.otherlinseed
dc.subject.othersecoisolariciresinol diglucoside
dc.subject.otherhigh-carbohydrate
dc.subject.otherhigh-fat diet
dc.subject.otheranthropometric indices
dc.subject.othercardiometabolic risk
dc.subject.otherelderly
dc.subject.otherrisk
dc.subject.otherpediatric
dc.subject.otheradolescent
dc.subject.othersugar-sweetened beverages
dc.subject.otherweight gain
dc.subject.othertype 2 diabetes
dc.subject.otherolder adults
dc.subject.othermacronutrient intake
dc.subject.otherdietary intake
dc.subject.otherfat intake
dc.subject.otherendocannabinoids
dc.subject.otherendocannabinoidome
dc.subject.othermicrobiome
dc.subject.otherfructose
dc.subject.otherhypertriglyceridemia
dc.subject.othermetabolism
dc.subject.othersleep
dc.subject.othersleep apnea
dc.subject.othersleep habit
dc.subject.othersleep duration
dc.subject.otherchronotype
dc.subject.othersocial jetlag
dc.subject.otherethnicity
dc.subject.otherprevention
dc.subject.otherlifestyle
dc.subject.othercardiometabolic
dc.subject.otherexercise
dc.subject.otherabdominal obesity
dc.subject.otherenergy balance
dc.subject.othercaloric restriction
dc.subject.othernon-alcoholic fatty liver disease
dc.subject.otherphysical activity
dc.subject.othersaturated fatty acids
dc.subject.otherdiet quality
dc.subject.otherdietary guidelines
dc.subject.othern/a
dc.titleMetabolic Syndrome
dc.title.alternativeFrom Etiology to Prevention and Clinical Management
dc.typebook
oapen.identifier.doi10.3390/books978-3-03943-990-4
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783039439898
oapen.relation.isbn9783039439904
oapen.pages348
oapen.place.publicationBasel, Switzerland


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/